Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 200 shares, a growth of 100.0% from the October 15th total of 100 shares. Based on an average daily trading volume, of 300 shares, the short-interest ratio is presently 0.7 days.
Aspen Pharmacare Price Performance
Aspen Pharmacare stock remained flat at $9.47 during mid-day trading on Friday. The company had a trading volume of 51 shares, compared to its average volume of 260. Aspen Pharmacare has a fifty-two week low of $9.26 and a fifty-two week high of $13.69. The company has a quick ratio of 1.07, a current ratio of 1.81 and a debt-to-equity ratio of 0.30. The firm’s 50 day moving average is $10.70 and its 200-day moving average is $11.95.
Aspen Pharmacare Cuts Dividend
The firm also recently announced a dividend, which was paid on Tuesday, October 8th. Stockholders of record on Friday, September 20th were paid a $0.1202 dividend. The ex-dividend date of this dividend was Friday, September 20th.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Read More
- Five stocks we like better than Aspen Pharmacare
- The How and Why of Investing in Gold Stocks
- Top-Performing Non-Leveraged ETFs This Year
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What is the Nasdaq? Complete Overview with History
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.